SCHEMBL18392286

SCHEMBL18392286

O=c1c(Cl)c(-c2c[nH]c3ncccc23)c1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 8/20 0.52
PIM1 P11309 7/20 0.52
MAP4K4 O95819 7/20 0.52
CLK4 Q9HAZ1 6/20 0.52
PRKACA P17612 6/20 0.52
GSK3B P49841 6/20 0.52
CDK9 P50750 5/20 0.52
CDK5 Q00535 5/20 0.52
DYRK1A Q13627 5/20 0.52
HIPK2 Q9H2X6 5/20 0.52
DAPK3 O43293 4/20 0.52
CLK2 P49760 4/20 0.52
CDK7 P50613 4/20 0.52
PRKX P51817 4/20 0.52
CDK8 P49336 4/20 0.52
STK17A Q9UEE5 4/20 0.52
FLT3 P36888 3/20 0.52
PKN2 Q16513 3/20 0.52
MINK1 Q8N4C8 3/20 0.52
CDK2 P24941 5/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5618155 0.78 TGFBR1 (0.71) CDC7PIM1MAP4K4CLK4PRKACA
SCHEMBL18392393 0.74 SIRT2 (0.53) PIM1PRKACAGSK3BCDK2PRKD3
SCHEMBL1043490 0.74 CDC7 (0.82) CDC7PIM1MAP4K4CLK4PRKACA
SCHEMBL18392230 0.74 DYRK1A (0.54) PIM1MAP4K4CLK4GSK3BCDK9
SCHEMBL1050911 0.73 TGFBR1 (0.60) CDC7PIM1MAP4K4CLK4PRKACA
SCHEMBL16705131 0.73 FLT3 (0.67) CDC7PIM1MAP4K4CLK4PRKACA
SCHEMBL20846051 0.73 RPS6KA5 (0.58) CDC7PIM1MAP4K4CLK4PRKACA
SCHEMBL858766 0.73 CAMKK2 (0.64) CDC7PIM1MAP4K4CLK4PRKACA
SCHEMBL18392287 0.71 PIM1 (0.52) CDC7PIM1MAP4K4CLK4PRKACA
SCHEMBL31097189 0.71 AXL (0.60) CDC7PIM1MAP4K4CLK4PRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3319940-B1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME UNIV BRAUNSCHWEIG TECH (DE) 2019-05-29 EP disclosed
US-10287271-B2 Indole compounds having antiprotozoal activity and its use as well as methods for producing the same TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) 2019-05-14 US disclosed
US-10287271-B2 Indole compounds having antiprotozoal activity and its use as well as methods for producing the same TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) 2019-05-14 US disclosed
US-20180194750-A1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) 2018-07-12 US disclosed
US-20180194750-A1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) 2018-07-12 US disclosed
US-20180194750-A1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) 2018-07-12 US disclosed
WO-2017008826-A1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) 2017-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180194750-A1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME IDO1, IDO2, INMT CDC7 2247/4885PIM1 2093/4885MAP4K4 4139/4885
US-10287271-B2 Indole compounds having antiprotozoal activity and its use as well as methods for producing the same IDO1, IDO2, INMT CDC7 2139/4885PIM1 1922/4885MAP4K4 4057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.